XGN Competitors & Alternatives
Compare Exagen Inc with similar stocks in the same industry
Diagnostics & Research
XGN
Main Stock$4.54
Tradestie Score
50
Market Cap
$241.60M
Revenue Growth
0.1%
Analyst Upside
+88.8%
Top Competitors
40 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CDNA
CareDx, Inc.
|
$29.19
|
$798.40M | - | 55 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$20.85
|
$719.31M | - | 58 | Compare |
|
MYGN
Myriad Genetics Inc
|
$5.99
|
$719.23M | - | 50 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$24.11
|
$667.77M | - | 56 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$13.62
|
$612.76M | - | 56 | Compare |
|
FULC
Fulcrum Therapeutics, Inc. Common Stock
|
$3.84
|
$504.67M | - | 59 | Compare |
|
APYX
Apyx Medical Corporation Common Stock
|
$4.30
|
$81.31M | - | 56 | Compare |
|
BDSX
Biodesix, Inc. Common Stock
|
$21.99
|
$61.36M | - | 58 | Compare |
|
TELA
TELA Bio, Inc. Common Stock
|
$0.72
|
$59.42M | - | 49 | Compare |
|
VRCA
Verrica Pharmaceuticals Inc. Common Stock
|
$6.14
|
$41.94M | - | 50 | Compare |
More XGN Analysis
Data updated: Jul 04, 2026 | Industry: Diagnostics & Research (SIC 8071)
40 stocks in this industry